Abstract:Abstract Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of Chinese DAH and compare them to comparable trends among OECD Development Assistance Committee (DAC) donors using data from the AidData’s Global Chinese Development Finance Dataset (2000–2017, version 2.0) and the Creditor Reporting System (CRS) database (2000–2017). We also analyse Chinese medical aid exports before and after the start of the COVID-19 pandemic using a Chinese Aid Exports Database. We further explore the potential factors influencing China’s shifting priority-setting processes by reviewing Chinese official documents following Walt and Gilson’s policy analysis framework (context–actors–process–content) and by testing our conjectures empirically. We find that China has become an important DAH donor to most regions if measured using project value, including but not limited to Africa. China has prioritized aid to African and Asian countries as well as to CRS subsectors that are not prioritized by DAC donors, such as medical services and basic health infrastructure. Chinese quarterly medical aid exports almost quintupled after the start of the COVID-19 pandemic. Noticeably, China has allocated more attention to Asia, eye diseases and infectious disease outbreaks over time. In contrast, the priority given to malaria has declined over the same period. Regarding factors affecting priority shifts, the outbreaks of SARS and Ebola, the launch of the Belt and Road Initiative and the COVID-19 pandemic appear to be important milestones in the timeline of Chinese DAH. Unlike stereotypes of China as a ‘lone wolf’ donor, our analysis suggests multilateral processes are influential in informing and setting Chinese DAH priorities.

The political economy of vaccine distribution and China's Belt and Road Initiative

Vaccine diplomacy: nation branding and China’s COVID-19 soft power play

China’s COVID-19 Vaccine Cooperation with Southeast Asia: A Boost for the Health Silk Road Initiative

Mask Diplomacy? Understanding China's Goals in Delivering Medical Aid in the First Wave of the COVID-19 Pandemic

Supply Chains Create Global Benefits from Improved Vaccine Accessibility

Building Bridges or Breaking Bonds? The Belt and Road Initiative and Foreign Aid Competition

China's Silk Road and global health.

The Application of Mask Diplomacy: China’s Belt and Road Initiative as Health Diplomacy in Middle East and North Africa (MENA) Countries During COVID-19

China's Belt and Road Initiative: Incorporating Public Health Measures Toward Global Economic Growth and Shared Prosperity

Equitable vaccine distribution promotes socioeconomic benefits globally

Prioritizing ‘equity’ in COVID-19 vaccine distribution through Global Health Diplomacy

COVID-19 and Chinese Global Health Diplomacy: Geopolitical Opportunity for China’s Hegemony?

China's Foreign Aid Political Drivers: Lessons from a Novel Dataset of Mask Diplomacy in Latin America during the COVID-19 Pandemic

Understanding China’s shifting priorities and priority-setting processes in development assistance for health

The Belt and Road Initiative and Disease Control Amid the COVID-19 Pandemic

China and the Global Search for Health Security: History, Vaccines, and Governance

Pursuing equitable access to vaccines for the next epidemic

CHINA’S GROWING INVOLVEMENT IN GLOBAL HEALTH GOVERNANCE

The Belt and Road Initiative: Issues and Future Trends

The Belt and Road Initiative: Impact on Trade Patterns Between China and Central Asia

COVID-19 vaccine intercountry distribution inequality and its underlying factors: a combined concentration index analysis and multiple linear regression analysis